Sex steroid ablation enhances lymphoid recovery following autologous hematopoietic stem cell transplantation

Transplantation

Volumn 80, Issue 11, 2005, Pages 1604-1613

  Goldberg, Gabrielle L ^a   Sutherland, Jayne S ^a   Hammet, Maree V ^a   Milton, Morag K ^a   Heng, Tracy S P ^a   Chidgey, Ann P ^a   Boyd, Richard L ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Castration; Hematopoiesis; Hematopoietic stem cell transplantation; Immune reconstitution; Sex steroids

Indexed keywords

GROWTH FACTOR; INTERLEUKIN 6; SEX HORMONE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; B LYMPHOCYTE; BONE MARROW; BONE MARROW CELL; CASTRATION; CELL POPULATION; CONTROLLED STUDY; DENDRITIC CELL; LYMPHOID CELL; LYMPHOPOIESIS; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; STATISTICAL SIGNIFICANCE; STROMA CELL; T LYMPHOCYTE; THYMOCYTE;

ANDROGENS; ANIMALS; B-LYMPHOCYTES; BONE MARROW CELLS; MALE; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; ORCHIECTOMY; STEM CELL TRANSPLANTATION; THYMUS GLAND; TRANSPLANTATION, AUTOLOGOUS;

EID: 29344458032     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000183962.64777.da     Document Type: Article

References (84)

1. Wingard JR. Opportunistic infections after blood and marrow transplantation. Transpl Infect Dis 1999; 1 (1): 3.
2. Stirewalt DL, Guthrie KA, Beppu L, et al. Predictors of relapse and overall survival in Philadelphia chromosome-positive acute lymphoblastic leukemia after transplantation. Biol Blood Marrow Transplant 2003; 9 (3): 206.
3. Robinson SN, Freedman AS, Neuberg DS, et al. Loss of marrow reserve from dose-intensified chemotherapy results in impaired hematopoietic reconstitution after autologous transplantation: CD34(+), CD34(+) 38(-), and week-6 CAFC assays predict poor engraftment. Exp Hematol 2000; 28 (12): 1325.
4. Sugita K, Soiffer RJ, Murray C, et al. The phenotype and reconstitution of immunoregulatory T cell subsets after T cell-depleted allogeneic and autologous bone marrow transplantation. Transplantation 1994; 57 (10): 1465.
5. Reimer P, Kunzmann V, Wilhelm M, et al. Cellular and humoral immune reconstitution after autologous peripheral blood stem cell transplantation (PBSCT). Ann Hematol 2003; 82 (5): 263.
6. Mackall CL, Gress RE. Thymic aging and T-cell regeneration. Immunol Rev 1997; 160: 91.
7. Olsen GA, Gockerman JP, Bast RC Jr., et al. Altered immunologic reconstitution after standard-dose chemotherapy or high-dose chemotherapy with autologous bone marrow support. Transplantation 1988; 46 (1): 57.
8. Bengtsson M, Totterman TH, Smedmyr B, et al. Regeneration of functional and activated NK and T sub-subset cells in the marrow and blood after autologous bone marrow transplantation: a prospective phenotypic study with 2/3-color FACS analysis. Leukemia 1989; 3(1): 68.
9. Miller RA, Daley J, Ghalie R, Kaizer H. Clonal analysis of T-cell deficiencies in autotransplant recipients. Blood 1991; 77 (8): 1845.
10. Cayeux S, Meuer S, PezzuttoA, et al. T-cell ontogeny after autologous bone marrow transplantation: failure to synthesize interleukin-2 (IL-2) and lack of CD2- and CD3-mediated proliferation by both CD4- and CD8+ cells even in the presence of exogeneous IL-2. Blood 1989; 74 (6): 2270.
11. Sugita K, Nojima Y, Tachibana K, et al. Prolonged impairment of very late activating antigen-mediated T cell proliferation via the CD3 pathway after T cell-depleted allogeneic bone marrow transplantation. J Clin Invest 1994; 94 (2): 481.
12. Katsanis E, Anderson PM, Filipovich AH, et al. Proliferation and cytolytic function of anti-CD3 + interleukin-2 stimulated peripheral blood mononuclear cells following bone marrow transplantation. Blood 1991; 78 (5): 1286.
13. Cayeux S, Meuer S, Pezzutto A, et al. Allogeneic mixed lymphocyte reactions during a second round of ontogeny: normal accessory cells did not restore defective interleukin-2 (IL-2) synthesis in T cells but induced responsiveness to exogeneous IL-2. Blood 1989; 74 (6): 2278.
14. Keever CA, Welte K, Small T, et al. Interleukin 2-activated killer cells in patients following transplants of soybean lectin-separated and E rosette-depleted bone marrow. Blood 1987; 70 (6): 1893.
15. Mariani S, Coscia M, Even J, et al. Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusion. Br J Haematol 2001; 113 (4): 1051.
16. Guillaume T, Rubinstein DB, Symann M. Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood 1998; 92 (5): 1471.
17. Small TN, Keever CA, Weiner-Fedus S, et al. B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny. Blood 1990; 76 (8): 1647.
18. Mackall CL, Granger L, Sheard MA, et al. T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny. Blood 1993; 82 (8): 2585.
19. Mackall CL, Bare CV, Granger LA, et al. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol 1996; 156 (12): 4609.
20. Greenstein BD, Fitzpatrick FT, Adcock IM, et al. Reappearance of the thymus in old rats after orchidectomy: inhibition of regeneration by testosterone. J Endocrinol 1986; 110 (3): 417.
21. Windmill KF, Meade BJ, Lee VW. Effect of prepubertal gonadectomy and sex steroid treatment on the growth and lymphocyte populations of the rat thymus. Reprod Fertil Dev 1993; 5 (1): 73.
22. Nabarra B, Andrianarison I. Ultrastructural study of thymic microenvironment involution in aging mice. Exp Gerontol 1996; 31 (4): 489.
23. Fitzpatrick FT, Kendall MD, Wheeler MJ, et al. Reappearance of thymus of ageing rats after orchidectomy. J Endocrinol 1985; 106 (3): R17.
24. Marchetti B, Guarcello V, Morale MC, et al. Luteinizing hormone-releasing hormone (LHRH) agonist restoration of age-associated decline of thymus weight, thymic LHRH receptors, and thymocyte proliferative capacity. Endocrinology 1989; 125 (2): 1037.
25. Steffens CM, Al-Harthi L, Shott S, et al. Evaluation of thymopoiesis using T cell receptor excision circles (TRECs): differential correlation between adult and pediatric TRECs and naive phenotypes. Clin Immunol 2000; 97 (2): 95.
26. Sempowski GD, Gooding ME, Liao HX, et al. T cell receptor excision circle assessment of thymopoiesis in aging mice. Mol Immunol 2002; 38 (11): 841.
27. Ernst DN, Hobbs MV, Torbett BE, et al. Differences in the expression profiles of CD45RB, Pgp-1, and 3G11 membrane antigens and in the patterns of lymphokine secretion by splenic CD4+ T cells from young and aged mice. J Immunol 1990; 145 (5): 1295.
28. Kurashima C, Utsuyama M, Kasai M, et al. The role of thymus in the aging of Th cell subpopulations and age-associated alteration of cytokine production by these cells. Int Immunol 1995; 7 (1): 97.
29. Utsuyama M, Hirokawa K, Kurashima C, et al. Differential age-change in the numbers of CD4+CD45RA+ and CD4+CD29+ T cell subsets in human peripheral blood. Mech Ageing Dev 1992; 63 (1): 57.
30. Mosley RL, Koker MM, Miller RA. Idiosyncratic alterations of TCR size distributions affecting both CD4 and CD8 T cell subsets in aging mice. Cell Immunol 1998; 189 (1): 10.
31. LeMaoult J, Messaoudi I, Manavalan JS, et al. Age-related dysregulation in CD8 T cell homeostasis: kinetics of a diversity loss. J Immunol 2000; 165 (5): 2367.
32. Hertogh-Huijbregts A, Vissinga C, Rozing J, Nagelkerken L. Impairment of CD3-dependent and CD3-independent activation pathways in CD4+ and in CD8+ T cells from old CBA/RIJ mice. Mech Ageing Dev 1990; 53 (2): 141.
33. Flurkey K, Miller RA, Harrison DE. Cellular determinants of age-related decrements in the T-cell mitogen response of B6CBAF1 mice. J Gerontol 1992; 47 (4): B115.
34. Kirschmann DA, Murasko DM. Splenic and inguinal lymph node T cells of aged mice respond differently to polyclonal and antigen-specific stimuli. Cell Immunol 1992; 139 (2): 426.
35. LeMaoult J, Manavalan JS, Dyall R, et al. Cellular basis of B cell clonal populations in old mice. J Immunol 1999; 162 (11): 6384.
36. Weksler ME. Changes in the B-cell repertoire with age. Vaccine 2000; 18 (16): 1624.
37. Nicoletti C, Yang X, Cerny J. Repertoire diversity of antibody response to bacterial antigens in aged mice. III. Phosphorylcholine antibody from young and aged mice differ in structure and protective activity against infection with Streptococcus pneumoniae. J Immunol 1993; 150 (2): 543.
38. Utsuyama M, Hirokawa K, Mancini C, et al. Differential effects of gonadectomy on thymic stromal cells in promoting T cell differentiation in mice. Mech Ageing Dev. 1995; 81(2-3): 107.
39. Wei XY, Zhang JK, Li J, Chen SB. Effect of bilateral testicular resection on thymocyte and its microenvironment in aged mice. Asian J Androl 2001; 3 (4): 271.
40. Utsuyama M, Hirokawa K. Hypertrophy of the thymus and restoration of immune functions in mice and rats by gonadectomy. Mech Ageing Dev 1989; 47 (3): 175.
41. Moron G, Maletto B, Ropolo A, Pistoresi-Palencia MC. Changes in the development of experimental autoimmune prostatitis (EAP) by castration in aged rats. Dev Comp Immunol. 2000; 24(6-7): 673.
42. Roden AC, Moser MT, Tri SD, et al. Augmentation of T cell levels and responses induced by androgen deprivation. J Immunol 2004; 173 (10): 6098.
43. Erben RG, Raith S, Eberle J, Stangassinger M. Ovariectomy augments B lymphopoiesis and generation of monocyte-macrophage precursors in rat bone marrow. Am J Physiol 1998; 274 (3 Pt 1): E476.
44. Masuzawa T, Miyaura C, Onoe Y, et al. Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow. J Clin Invest 1994; 94 (3): 1090.
45. Ellis TM, Moser MT, Le PT, et al. Alterations in peripheral B cells and B cell progenitors following androgen ablation in mice. Int Immunol 2001; 13 (4): 553.
46. Gray DH, Chidgey AP, Boyd RL. Analysis of thymic stromal cell populations using flow cytometry. J Immunol Methods. 2002; 260(1-2): 15.
47. Oka S, Kubo K, Matsuyama S, Takamori Y. Flow cytometric analysis of thymocyte subpopulations in mice after whole-body X-irradiation. J Vet Med Sci 1999; 61 (6): 709.
48. Haraguchi K, Takahashi T, Hiruma K, et al. Recovery of Valpha24 + NKT cells after hematopoietic stem cell transplantation. Bone Marrow Transplant 2004; 34 (7): 595.
49. Chung B, Barbara-Burnham L, Barsky L, Weinberg K. Radiosensitivity of thymic interleukin-7 production and thymopoiesis after bone marrow transplantation. Blood 2001; 98 (5): 1601.
50. Storek J, Joseph A, Espino G, et al. Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation. Blood 2001; 98 (13): 3505.
51. Lewin SR, Heller G, Zhang L, et al. Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations. Blood 2002; 100 (6): 2235.
52. Kalwak K, Gorczynska E, Toporski J, et al. Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery. Br J Haematol 2002; 118 (1): 74.
53. Mackall CL, Fleisher TA, Brown MR, et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995; 332 (3): 143.
54. Siena S, Schiavo R, Pedrazzoli P, Carlo-Stella C. Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy. J Clin Oncol 2000; 18 (6): 1360.
55. Shpall EJ, Champlin R, Glaspy JA. Effect of CD34+ peripheral blood progenitor cell dose on hematopoietic recovery. Biol Blood Marrow Transplant 1998; 4 (2): 84.
56. Mavroudis D, Read E, Cottler-Fox M, et al. CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood 1996; 88 (8): 3223.
57. Cancelas JA, Querol S, Canals C, et al. Peripheral blood CD34+ cell immunomagnetic selection in breast cancer patients: effect on hematopoietic progenitor content and hematologic recovery after high-dose chemotherapy and autotransplantation. Transfusion 1998; 38 (11-12): 1063.
58. Kouro T, Medina KL, Oritani K, Kincade PW. Characteristics of early murine B-lymphocyte precursors and their direct sensitivity to negative regulators. Blood 2001; 97 (9): 2708.
59. Medina KL, Garrett KP, Thompson LF, et al. Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen. Nat Immunol 2001; 2 (8): 718.
60. Girasole G, Jilka RL, Passeri G, et al. 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 1992; 89 (3): 883.
61. Smithson G, Medina K, Ponting I, Kincade PW. Estrogen suppresses stromal cell-dependent lymphopoiesis in culture. J Immunol 1995; 155 (7): 3409.
62. Thurmond TS, Murante FG, Staples JE, et al. Role of estrogen receptor alpha in hematopoietic stem cell development and B lymphocyte maturation in the male mouse. Endocrinology 2000; 141 (7): 2309.
63. Batard P, Monier MN, Fortunel N, et al. TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation. J Cell Sci 2000; 113 (Pt 3): 383.
64. Fan X, Valdimarsdottir G, Larsson J, et al. Transient disruption of autocrine TGF-beta signaling leads to enhanced survival and proliferation potential in single primitive human hemopoietic progenitor cells. J Immunol 2002; 168 (2): 755.
65. Olsen NJ, Gu X, Kovacs WJ. Bone marrow stromal cells mediate androgenic suppression of B lymphocyte development. J Clin Invest 2001; 108 (11): 1697.
66. Tang J, Nuccie BL, Ritterman I, et al. TGF-beta down-regulates stromal IL-7 secretion and inhibits proliferation of human B cell precursors. J Immunol 1997; 159 (1): 117.
67. Arber C, BitMansour A, Sparer TE, et al. Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation. Blood 2003; 102 (2): 421.
68. Mackall CL, Hakim FT, Gress RE. Restoration of T-cell homeostasis after T-cell depletion. Semin Immunol 1997; 9 (6): 339.
69. Almeida AR, Borghans JA, Freitas AA. T cell homeostasis: thymus regeneration and peripheral T cell restoration in mice with a reduced traction of competent precursors. J Exp Med 2001; 194 (5): 591.
70. Scollay RG, Butcher EC, Weissman IL. Thymus cell migration. Quantitative aspects of cellular traffic from the thymus to the periphery in mice. Eur J Immunol 1980; 10 (3): 210.
71. Garcia-Suarez O, Perez-Perez M, Germana A, et al. Involvement of growth factors in thymic involution. Microsc Res Tech 2003; 62 (6): 514.
72. van den Brink MR, Alpdogan O, Boyd RL. Strategies to enhance T-cell reconstitution in immunocompromised patients. Nat Rev Immunol 2004; 4 (11): 856.
73. Aspinall R, Andrew D. Thymic atrophy in the mouse is a soluble problem of the thymic environment. Vaccine 2000; 18 (16): 1629.
74. Andrew D, Aspinall R. Age-associated thymic atrophy is linked to a decline in IL-7 production. Exp Gerontol 2002; 37(2-3): 455.
75. Ortman CL, Dittmar KA, Witte PL, Le PT. Molecular characterization of the mouse involuted thymus: aberrations in expression or transcription regulators in thymocyte and epithelial compartments. Int Immunol 2002; 14 (7): 813.
76. Alpdogan O, Schmaltz C, Muriglan SJ, et al. Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. Blood 2001; 98 (7): 2256.
77. Bolotin E, Smogorzewska M, Smith S, et al. Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood 1996; 88 (5): 1887.
78. Faltynek CR, Wang S, Miller D, et al. Administration of human recombinant IL-7 to normal and irradiated mice increases the numbers of lymphocytes and some immature cells of the myeloid lineage. J Immunol 1992; 149 (4): 1276.
79. Morrissey PJ, Conlon P, Braddy S, et al. Administration of IL-7 to mice with cyclophosphamide-induced lymphopenia accelerates lymphocyte repopulation. J Immunol 1991; 146 (5): 1547.
80. Sempowski GD, Hale LP, Sundy JS, et al. Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy. J Immunol 2000; 164 (4): 2180.
81. Mackall CL, Fry TJ, Bare C, et al. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood 2001; 97 (5): 1491.
82. Tu Y, Du J, Yang A. Expression and cellular localization of interleukin-6 mRNA in ovariectomized rats. J Tongji Med Univ 2000; 20 (2): 145.
83. Olsen NJ, Zhou P, Ong H, Kovacs WJ. Testosterone induces expression of transforming growth factor-beta 1 in the murine thymus. J Steroid Biochem Mol Biol 1993; 45 (5): 327.
84. Gill RK, Turner RT, Wronski TJ, Bell NH. Orchiectomy markedly reduces the concentration of the three isoforms of transforming growth factor beta in rat bone, and reduction is prevented by testosterone. Endocrinology 1998; 139 (2): 546.